Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors

被引：216

作者：

Theruvath, Johanna ^{[1
]}

Sotillo, Elena ^{[1
]}

Mount, Christopher W. ^{[2
]}

Graef, Claus Moritz ^{[1
]}

Delaidelli, Alberto ^{[3
]}

Heitzeneder, Sabine ^{[1
]}

Labanieh, Louai ^{[1
,4
]}

Dhingra, Shaurya ^{[1
]}

Leruste, Amaury ^{[1
]}

Majzner, Robbie G. ^{[1
,5
]}

Xu, Peng ^{[1
]}

Mueller, Sabine ^{[6
,7
,8
,19
]}

Yecies, Derek W. ^{[9
]}

Finetti, Martina A. ^{[10
]}

Williamson, Daniel ^{[10
]}

Johann, Pascal D. ^{[1
,11
,12
,13
]}

Kool, Marcel ^{[11
,12
,13
]}

Pfister, Stefan ^{[11
,12
,13
,14
]}

Hasselblatt, Martin ^{[15
]}

Fruehwald, Michael C. ^{[16
,17
]}

Delattre, Olivier ^{[18
,19
]}

Surdez, Didier ^{[18
,19
]}

Bourdeaut, Franck ^{[1
,18
,19
]}

Puget, Stephanie ^{[20
]}

Zaidi, Sakina ^{[18
,19
]}

Mitra, Siddhartha S. ^{[21
]}

Cheshier, Samuel ^{[22
,23
]}

Sorensen, Poul H. ^{[3
]}

Monje, Michelle ^{[1
,2
,5
,9
,24
,25
]}

Mackall, Crystal L. ^{[1
,5
,26
]}

机构：

[1] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA

[3] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada

[4] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA

[5] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA

[6] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA

[7] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA

[8] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA

[9] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA

[10] Newcastle Univ, Northern Inst Canc Res, Wolfson Childhood Canc Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[11] Hopp Childrens Canc Ctr Heidelberg, Heidelberg, Germany

[12] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany

[13] German Canc Consortium, Heidelberg, Germany

[14] Heidelberg Univ Hosp, Dept Pediat Hematol & Oncol, Heidelberg, Germany

[15] Munster Univ Hosp, Inst Neuropathol, Munster, Germany

[16] Univ Childrens Hosp Augsburg, Swabian Childrens Canc Ctr, Augsburg, Germany

[17] EU RHAB Registry Ctr, Augsburg, Germany

[18] Paris Sci Lettres Res Univ, INSERM, U830, Paris, France

[19] Paris Sci Lettres Res Univ, SIREDO Care Innovat & Res Children Adolescents &, Inst Curie, Paris, France

[20] Paris Univ, Necker Enfants Malad Hosp, AP HP, Dept Neurosurg, Paris, France

[21] Univ Colorado Anschutz Med Campus, Pediat, Aurora, CO USA

[22] Univ Utah, Primary Childrens Hosp, Dept Neurosurg, Div Pediat Neurosurg, Salt Lake City, UT USA

[23] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[24] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA

[25] Stanford Univ, Stanford Inst Stem Cell & Regenerat Med, Sch Med, Stanford, CA 94305 USA

[26] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA

来源：

NATURE MEDICINE | 2020年 / 26卷 / 05期

基金：

欧盟地平线“2020”; 美国国家卫生研究院;

关键词：

ANTIGEN; CANCER; B7-H3; EXPRESSION; EFFICACY; SURVIVAL; THERAPY; ABSENCE; TARGETS; HER2;

D O I：

10.1038/s41591-020-0821-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Atypical teratoid/rhabdoid tumors (ATRTs) typically arise in the central nervous system (CNS) of children under 3 years of age. Despite intensive multimodal therapy (surgery, chemotherapy and, if age permits, radiotherapy), median survival is 17 months(1,2). We show that ATRTs robustly express B7-H3/CD276 that does not result from the inactivating mutations in SMARCB1 (refs. (3,4)), which drive oncogenesis in ATRT, but requires residual SWItch/Sucrose Non-Fermentable (SWI/SNF) activity mediated by BRG1/SMARCA4. Consistent with the embryonic origin of ATRT(5,6), B7-H3 is highly expressed on the prenatal, but not postnatal, brain. B7-H3.BB.z-chimeric antigen receptor (CAR) T cells administered intracerebroventricularly or intratumorally mediate potent antitumor effects against cerebral ATRT xenografts in mice, with faster kinetics, greater potency and reduced systemic levels of inflammatory cytokines compared to CAR T cells administered intravenously. CAR T cells administered ICV also traffic from the CNS into the periphery; following clearance of ATRT xenografts, B7-H3.BB.z-CAR T cells administered intracerebroventricularly or intravenously mediate antigen-specific protection from tumor rechallenge, both in the brain and periphery. These results identify B7-H3 as a compelling therapeutic target for this largely incurable pediatric tumor and demonstrate important advantages of locoregional compared to systemic delivery of CAR T cells for the treatment of CNS malignancies. CAR T cells administered intracerebroventricularly or intratumorally exhibit more rapid kinetics, reduced systemic toxicity and greater therapeutic potency as compared to intravenously delivered CAR T cells in atypical teratoid/rhabdoid tumor xenograft mouse models.

引用

页码：712 / +

页数：22

共 49 条

[31] Longitudinal observation on CSF Aβ42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic mice [J].

Liu, L ;

Herukka, SK ;

Minkeviciene, R ;

van Groen, T ;

Tanila, H .

NEUROBIOLOGY OF DISEASE, 2004, 17 (03) :516-523

[32] Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity [J].

Loo, Deryk ;

Alderson, Ralph F. ;

Chen, Francine Z. ;

Huang, Ling ;

Zhang, Wenjun ;

Gorlatov, Sergey ;

Burke, Steve ;

Ciccarone, Valentina ;

Li, Hua ;

Yang, Yinhua ;

Son, Tom ;

Chen, Yan ;

Easton, Ann N. ;

Li, Jonathan C. ;

Rillema, Jill R. ;

Licea, Monica ;

Fieger, Claudia ;

Liang, Tony W. ;

Mather, Jennie P. ;

Koenig, Scott ;

Stewart, Stanford J. ;

Johnson, Syd ;

Bonvini, Ezio ;

Moore, Paul A. .

CLINICAL CANCER RESEARCH, 2012, 18 (14) :3834-3845

[33] Clinical lessons learned from the first leg of the CAR T cell journey [J].

Majzner, Robbie G. ;

Mackall, Crystal L. .

NATURE MEDICINE, 2019, 25 (09) :1341-1355

[34] CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors [J].

Majzner, Robbie G. ;

Theruvath, Johanna L. ;

Nellan, Anandani ;

Heitzeneder, Sabine ;

Cui, Yongzhi ;

Mount, Christopher W. ;

Rietberg, Skyler P. ;

Linde, Miles H. ;

Xu, Peng ;

Rota, Christopher ;

Sotillo, Elena ;

Labanieh, Louai ;

Lee, Daniel W. ;

Orentas, Rimas J. ;

Dimitrov, Dimiter S. ;

Zhu, Zhongyu ;

St Croix, Brad ;

Delaidelli, Alberto ;

Sekunova, Alla ;

Bonvini, Ezio ;

Mitra, Siddhartha S. ;

Quezado, Martha M. ;

Majeti, Ravindra ;

Monje, Michelle ;

Sorensen, Poul H. B. ;

Maris, John M. ;

Mackall, Crystal L. .

CLINICAL CANCER RESEARCH, 2019, 25 (08) :2560-2574

[35] Tumor Antigen Escape from CAR T-cell Therapy [J].

Majzner, Robbie G. ;

Mackall, Crystal L. .

CANCER DISCOVERY, 2018, 8 (10) :1219-1226

[36] Transcriptional landscape of the prenatal human brain [J].

Miller, Jeremy A. ;

Ding, Song-Lin ;

Sunkin, Susan M. ;

Smith, Kimberly A. ;

Ng, Lydia ;

Szafer, Aaron ;

Ebbert, Amanda ;

Riley, Zackery L. ;

Royall, Joshua J. ;

Aiona, Kaylynn ;

Arnold, James M. ;

Bennet, Crissa ;

Bertagnolli, Darren ;

Brouner, Krissy ;

Butler, Stephanie ;

Caldejon, Shiella ;

Carey, Anita ;

Cuhaciyan, Christine ;

Dalley, Rachel A. ;

Dee, Nick ;

Dolbeare, Tim A. ;

Facer, Benjamin A. C. ;

Feng, David ;

Fliss, Tim P. ;

Gee, Garrett ;

Goldy, Jeff ;

Gourley, Lindsey ;

Gregor, Benjamin W. ;

Gu, Guangyu ;

Howard, Robert E. ;

Jochim, Jayson M. ;

Kuan, Chihchau L. ;

Lau, Christopher ;

Lee, Chang-Kyu ;

Lee, Felix ;

Lemon, Tracy A. ;

Lesnar, Phil ;

McMurray, Bergen ;

Mastan, Naveed ;

Mosqueda, Nerick ;

Naluai-Cecchini, Theresa ;

Ngo, Nhan-Kiet ;

Nyhus, Julie ;

Oldre, Aaron ;

Olson, Eric ;

Parente, Jody ;

Parker, Patrick D. ;

Parry, Sheana E. ;

Stevens, Allison ;

Pletikos, Mihovil .

NATURE, 2014, 508 (7495) :199-+

[37] Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas [J].

Mount, Christopher W. ;

Majzner, Robbie G. ;

Sundaresh, Shree ;

Arnold, Evan P. ;

Kadapakkam, Meena ;

Haile, Samuel ;

Labanieh, Louai ;

Hulleman, Esther ;

Woo, Pamelyn J. ;

Rietberg, Skyler P. ;

Vogel, Hannes ;

Monje, Michelle ;

Mackall, Crystal L. .

NATURE MEDICINE, 2018, 24 (05) :572-+

[38] A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma [J].

O'Rourke, Donald M. ;

Nasrallah, MacLean P. ;

Desai, Arati ;

Melenhorst, Jan J. ;

Mansfield, Keith ;

Morrissette, Jennifer J. D. ;

Martinez-Lage, Maria ;

Brem, Steven ;

Maloney, Eileen ;

Shen, Angela ;

Isaacs, Randi ;

Mohan, Suyash ;

Plesa, Gabriela ;

Lacey, Simon F. ;

Navenot, Jean-Marc ;

Zheng, Zhaohui ;

Levine, Bruce L. ;

Okada, Hideho ;

June, Carl H. ;

Brogdon, Jennifer L. ;

Maus, Marcela V. .

SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (399)

[39] Molecular diagnostics of CNS embryonal tumors [J].

Pfister, Stefan M. ;

Korshunov, Andrey ;

Kool, Marcel ;

Hasselblatt, Martin ;

Eberhart, Charles ;

Taylor, Michael D. .

ACTA NEUROPATHOLOGICA, 2010, 120 (05) :553-566

[40] Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2 thorn Breast Cancer Metastasis to the Brain [J].

Priceman, Saul J. ;

Tilakawardane, Dileshni ;

Jeang, Brook ;

Aguilar, Brenda ;

Murad, John P. ;

Park, Anthony K. ;

Chang, Wen-Chung ;

Ostberg, Julie R. ;

Neman, Josh ;

Jandial, Rahul ;

Portnow, Jana ;

Forman, Stephen J. ;

Brown, Christine E. .

CLINICAL CANCER RESEARCH, 2018, 24 (01) :95-105

← 1 2 3 4 5 →